Market revenue in 2023 | USD 29.1 million |
Market revenue in 2030 | USD 38.0 million |
Growth rate | 3.9% (CAGR from 2023 to 2030) |
Largest segment | 25-hydroxyvitamin d test |
Fastest growing segment | 25-hydroxyvitamin D Test |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 25-hydroxyvitamin D Test, 1, 25-Dihydroxy Vitamin D Test |
Key market players worldwide | Abbott Laboratories, Danaher Corp, Roche Holding AG, Siemens Healthineers AG ADR, Quest Diagnostics Inc, BioMerieux SA, Diasorin SpA, Thermo Fisher Scientific Inc, Beckman Coulter, Tosoh Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vitamin d testing market will help companies and investors design strategic landscapes.
25-hydroxyvitamin d test was the largest segment with a revenue share of 54.3% in 2023. Horizon Databook has segmented the Middle East & Africa vitamin d testing market based on 25-hydroxyvitamin d test, 1, 25-dihydroxy vitamin d test covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa vitamin d testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa vitamin d testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account